Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Outset Medical
OM
$74.9M
| $158K | ﹤0.01% |
41,162
| – | – |
|
3327
Lantronix
LTRX
$236M
| $157K | ﹤0.01% |
+30,000
| New | +$183K |
|
|
GAMB
3328
DELISTED
Gambling.com
GAMB
| $157K | ﹤0.01% |
40,513
-7,906
| -16% | -$35.5K |
|
3329
Invivyd
IVVD
$180M
| $153K | ﹤0.01% |
118,012
+92
| +0.1% | +$169 |
|
3330
Cartesian Therapeutics
RNAC
$232M
| $153K | ﹤0.01% |
24,929
-371
| -1% | -$2.64K |
|
|
CARL
3331
Carlsmed
CARL
$294M
| $152K | ﹤0.01% |
16,775
| – | – |
|
3332
Korro Bio
KRRO
$153M
| $152K | ﹤0.01% |
13,394
-2,935
| -18% | -$32.3K |
|
3333
HF Foods Group
HFFG
$83.2M
| $151K | ﹤0.01% |
81,839
-17,522
| -18% | -$33.5K |
|
|
CLYM
3334
Climb Bio
CLYM
$735M
| $151K | ﹤0.01% |
+22,051
| New | +$127K |
|
3335
Nerdy
NRDY
$107M
| $150K | ﹤0.01% |
184,366
-25
| -0% | -$24 |
|
3336
Lakeland Industries
LAKE
$106M
| $150K | ﹤0.01% |
18,345
-7,927
| -30% | -$71.4K |
|
3337
Avalo Therapeutics
AVTX
$976M
| $149K | ﹤0.01% |
+10,000
| New | +$156K |
|
3338
Ring Energy
REI
$322M
| $148K | ﹤0.01% |
97,041
-50
| -0.1% | -$64 |
|
|
FJET
3339
Starfighters Space Inc
FJET
$170M
| $148K | ﹤0.01% |
+25,000
| New | +$200K |
|
3340
NLI Holdings
NL
$284M
| $147K | ﹤0.01% |
25,248
+2
| +0% | +$12 |
|
3341
Mammoth Energy Services
TUSK
$132M
| $144K | ﹤0.01% |
58,861
-11,813
| -17% | -$26.9K |
|
3342
Prairie Operating Co
PROP
$78.2M
| $141K | ﹤0.01% |
69,641
-26,263
| -27% | -$47.4K |
|
3343
LENSAR
LNSR
$68.8M
| $141K | ﹤0.01% |
23,604
-4,862
| -17% | -$52.8K |
|
|
LFT
3344
Lument Finance Trust
LFT
$41.9M
| $140K | ﹤0.01% |
111,291
-24,993
| -18% | -$33.8K |
|
3345
Forafric Global
AFRI
$283M
| $139K | ﹤0.01% |
14,401
| – | – |
|
|
MAPS
3346
DELISTED
WM TECHNOLOGY INC A
MAPS
| $139K | ﹤0.01% |
210,413
-49,474
| -19% | -$36.3K |
|
3347
Cabaletta Bio
CABA
$439M
| $137K | ﹤0.01% |
50,824
| – | – |
|
3348
Southland Holdings
SLND
$33.6M
| $134K | ﹤0.01% |
103,302
-12,596
| -11% | -$22.6K |
|
|
AISP
3349
Airship AI Holdings
AISP
$69.2M
| $133K | ﹤0.01% |
58,953
-13,708
| -19% | -$38.9K |
|
3350
Palisade Bio
PALI
$339M
| $133K | ﹤0.01% |
+76,000
| New | +$138K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.